
Mexcef TZ 250mg/31.25mg Injection
Marketer
Comex Pharma
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Mexcef TZ 250mg/31.25mg Injection
Cefixime and Sulbactam injection (250mg/31.25mg), sold under the brand name Mexcef TZ, is a dual-action antibiotic. It's indicated for treating diverse bacterial infections by inhibiting microbial growth and halting infection progression. Administration should strictly follow a healthcare professional's guidance. Complete the prescribed dosage regimen; premature cessation may compromise efficacy. Missed doses should be avoided. Common adverse reactions include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects immediately to your physician. Seek urgent medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor about all current medications before initiating this treatment. Pregnant or lactating individuals must consult their physician prior to use. Alcohol consumption should be avoided due to the potential for increased drowsiness. While generally not impairing driving ability, avoid operating vehicles if experiencing somnolence or dizziness. Adequate rest, balanced nutrition, and sufficient hydration contribute to faster recovery. Your doctor may order lab tests to monitor the medication's impact.
Primary Ingredients of Mexcef TZ 250mg/31.25mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Mexcef TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Mexcef TZ 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Mexcef TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Mexcef TZ 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Mexcef TZ 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactum, combined as Mexcef TZ 250mg/31.25mg Injection, offer targeted antibacterial action. Ceftriaxone, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The addition of Tazobactum, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus maximizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Mexcef TZ 250mg/31.25mg Injection can be used concurrently with alcohol without adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Mexcef TZ, containing 250mg/31.25mg, is typically deemed safe for use in pregnancy. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human subjects are scarce.
Breast feedingCAUTION
The administration of Mexcef TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Mexcef TZ 250mg/31.25mg Injection may induce drowsiness, visual disturbances, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding the administration of Mexcef TZ 250mg/31.25mg Injection to individuals with renal impairment is scarce. Seek medical advice from your physician.
LiverCAUTION
Administering Mexcef TZ 250mg/31.25mg Injection requires careful consideration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Mexcef TZ 250mg/31.25mg Injection is not suggested for those with mild or moderate liver dysfunction.
What if you forget to take Mexcef TZ 250mg/31.25mg Injection :
Omit a Mexcef TZ 250mg/31.25mg Injection dose? Seek your physician's advice.
Facts to Know About Mexcef TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective Agents |
